RSP - On NSAIDs

32284245 ä. The Use of Nonsteroidal Anti-inflammatory Drugs in Urological Practice in the COVID-19 Era: Is ?Safe Better than Sorry??
32366317 2020. Covid-19 The real role of NSAIDs in Italy
32360482 2020. NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators?
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
32234728 2020. EMA advice on the use of NSAIDs for Covid-19
32220865 2020. Non-steroidal anti-inflammatory drugs and covid-19
32205306 2020. Covid-19: European drugs agency to review safety of ibuprofen
32184201 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
32253225 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases
C7149289 2020. Regulatory agencies issue advice on use of NSAIDs for COVID-19
32435882 2020. Model based approach for estimating the dosage regimen of indomethacin a potential antiviral treatment of patients infected with SARS CoV-2.
32460369 2020. Non-steroidal anti-inflammatory drugs in management of COVID-19; A systematic review on current evidence.
32412158 2020. Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2/COVID-19.
32303505 2020. Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear.
32530870 2020. Rapid Review: Nonsteroidal Anti-inflammatory Agents and Aminosalicylates in COVID-19 Infections.